Angle Quote - AGL

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

9.75

Bid

9.50

Offer

10.00

Volume

611,368

9.75 Day's Range 10.50

7.25 52 Week Range 37.50

Market Cap

31.458M

Previous Close

10.50

Open

10.50

Last Trade

5061

9.8

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,415,053

Shares Outstanding

322,641,668

Dividend Yield

PE Ratio

-1.56

Earnings Per Share (EPS)

-0.06

Revenue

2.19M

Net Profit

-20.13M

Sector

Business Services, Nec

Industry

Business Consulting

Website

www.angleplc.com

Headquarters

Guildford, Gbr

Founded

2003

Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 10.50p. Over the last year, Angle shares have traded in a share price range of 7.25p to 37.50p.

Angle currently has 322,641,668 shares in issue. The market capitalisation of Angle is £33.88 million. Angle has a price to earnings ratio (PE ratio) of -1.56.

Angle PLC HER2 presentation at SABCS

Angle PLC 13 December 2024 For immediate release 13 December 2024 ANGLE plc ("the Company") WEILL CORNELL MEDICINE PRESENTS HER2 PARSORTIX WORKFLOW AT SAN ANTONIO BREAST CANCER SYMPOSIUM...

Angle stock surges as firm showcases new assay products

Angle PLC on Friday said it is has presented data that highlights the potential of a new assay for lung cancer patien ...

Angle PLC Research on HER2 assay kit showcased at AACR

Angle PLC 15 November 2024 For immediate release 15 November 2024 ANGLE plc ("the Company") RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL...

Angle PLC Parsortix based PD-L1 assay showcased at AACR

Angle PLC 15 November 2024 For immediate release 15 November 2024 ANGLE plc ("the Company") parsortix-based pd-l1 assay showcased at international liquid biopsy conference CTC PD-L1...

Angle PLC ANGLE presents two posters at EACR

Angle PLC 13 November 2024 For immediate release 13 November 2024 ANGLE plc ("the Company") Parsortix-based assays showcased at the european association for cancer research liquid...

Angle notes use of Parsortix system in treatment resistance study

Angle PLC on Monday said its in-vitro diagnostic Parsortix system was successfully used in a non-small cell lung canc ...

Angle PLC Parsortix enriched CTC & ctDNA in NSCLC patients

Angle PLC 11 November 2024 For immediate release 11 November 2024 ANGLE plc ("the Company") DNA analysis of Parsortix-enriched CTCs and ctDNA provides complementary information in NSCLC...

Angle PLC Publication demonstrates CTC profiling potential

Angle PLC 17 October 2024 For immediate release 17 October 2024 ANGLE plc ("the Company") PUBLICATION DEMONSTRATES POTENTIAL FOR multi-marker CTC profiling IN EARLY PROSTATE CANCER ...

EARNINGS: Ebiquity bemoans poor conditions on swing to interim loss

The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported b ...

Angle PLC 100th publication supporting Parsortix system use

Angle PLC 26 September 2024 For immediate release 26 September 2024 ANGLE plc ("the Company") 100TH PUBLICATION SUPPORTING PARSORTIX SYSTEM USE Whole Genomic Sequencing and machine...

Angle stock surges as firm showcases new assay products

Angle PLC on Friday said it is has presented data that highlights the potential of a new assay for lung cancer patien ...

Angle notes use of Parsortix system in treatment resistance study

Angle PLC on Monday said its in-vitro diagnostic Parsortix system was successfully used in a non-small cell lung canc ...

EARNINGS: Ebiquity bemoans poor conditions on swing to interim loss

The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported b ...

Angle PLC Half-year Report

Angle PLC 26 September 2024 For Immediate Release 26 September 2024 ANGLE plc ("ANGLE" or "the Company") Interim Results for the six months ended 30 June 2024 LARGE PHARMA STRATEGY...

Angle PLC Exclusive agreement for DNA NGS panel

Angle PLC 23 September 2024 For immediate release 23 September 2024 ANGLE plc ("the Company") ANGLE ANNOUNCES NEXT GENERATION SEQUENCING ASSAY AGREEMENT WITH NUPROBE Option for...

IN BRIEF: Angle celebrates agreement with Recursion Pharmaceuticals

ford, England-based liquid biopsy company - Announces it has signed an agreement with Recursion Pharmaceuticals Inc, a ...

Angle PLC Notice of Interim Results and Webcast

Angle PLC 17 September 2024 For immediate release 17 September 2024 ANGLE plc ("the Company") Notice of Interim Results and Webcast ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading...

IN BRIEF: Angle hails publication of research data in science journal

ford, England-based liquid biopsy company - Celebrates research data on its Parsortix PC1 system that it says supports ...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.5	-13.3333333333	11.25	11.25	9.75	725613	10.59567483	DE
4	-1.75	-15.2173913043	11.5	11.5	9.75	788788	10.64635055	DE
12	1	11.4285714286	8.75	13	7.25	1415053	9.56844058	DE
26	-4.25	-30.3571428571	14	17	7.25	1168210	11.45014958	DE
52	-1.35	-12.1621621622	11.1	37.5	7.25	1994944	17.73522476	DE
156	-115.75	-92.2310756972	125.5	163.5	7.25	1554635	31.6917445	DE
260	-51.85	-84.1720779221	61.6	163.5	7.25	1212982	42.75632908	DE

AGL - Frequently Asked Questions (FAQ)

What is the current Angle share price?

The current share price of Angle is 9.75p

How many Angle shares are in issue?

Angle has 322,641,668 shares in issue

What is the market cap of Angle?

The market capitalisation of Angle is GBP 33.88M

What is the 1 year trading range for Angle share price?

Angle has traded in the range of 7.25p to 37.50p during the past year

What is the PE ratio of Angle?

The price to earnings ratio of Angle is -1.56

What is the cash to sales ratio of Angle?

The cash to sales ratio of Angle is 14.34

What is the reporting currency for Angle?

Angle reports financial results in GBP

What is the latest annual turnover for Angle?

The latest annual turnover of Angle is GBP 2.19M

What is the latest annual profit for Angle?

The latest annual profit of Angle is GBP -20.13M

What is the registered address of Angle?

The registered address for Angle is 10 NUGENT ROAD, THE SURREY RESEARCH PARK, GUILDFORD, GU2 7AF

What is the Angle website address?

The website address for Angle is www.angleplc.com

Which industry sector does Angle operate in?

Angle operates in the BUSINESS CONSULTING sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZENZenith Energy Ltd.	2.15p (34.38%)	8.65M
TM1Technology Minerals Plc	0.25p (31.58%)	221.41M
AEGActive Energy Group Plc	0.225p (28.57%)	20.4M
SNTSabien Technology Group Plc	12.75p (24.39%)	1.28M
VCPVictoria Plc	62.40p (18.63%)	4.78M
TRYBTribe Technology Plc	0.55p (-66.15%)	908.54k
APIAbrdn Property Income Trust Limited	6.32p (-32.55%)	5.65M
WEBWebis Holdings Plc	0.09p (-28.00%)	5.21M
GFINGfinity Plc	0.0575p (-25.81%)	224.82M
SOUSound Energy Plc	1.00p (-20.00%)	15.17M
NTVONativo Resources Plc	0.0019p (-9.52%)	592.34M
TRPTower Resources Plc	0.032p (-5.88%)	518.86M
SYNSynergia Energy Ltd	0.051p (4.08%)	312.86M
BCEBeacon Energy Plc	0.00375p (-6.25%)	254.5M
GFINGfinity Plc	0.0575p (-25.81%)	224.82M